Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Colorectal Neoplasms 476Carcinoma, Non-Small-Cell Lung 233Breast Neoplasms 196Ovarian Neoplasms 171Glioblastoma 157Carcinoma, Hepatocellular 131Neoplasms 128Rectal Neoplasms 114Colonic Neoplasms 110Neoplasm Metastasis 106Brain Neoplasms 97Lung Neoplasms 96Fallopian Tube Neoplasms 85Carcinoma, Renal Cell 77Glioma 69Pancreatic Neoplasms 54Liver Neoplasms 44Melanoma 43Gliosarcoma 43Uterine Cervical Neoplasms 40Adenocarcinoma of Lung 39Stomach Neoplasms 37Recurrence 33Astrocytoma 30Carcinoma, Ovarian Epithelial 28Endometrial Neoplasms 27Triple Negative Breast Neoplasms 26Kidney Neoplasms 23Prostatic Neoplasms 22Esophageal Neoplasms 21

Interventions

Bupivacaine 2Ultrasonography 1Therapeutics 1Surgical Procedures, Operative 1Sodium Chloride 1Ralfinamide 1Radiofrequency Ablation 1Nerve Conduction Studies 1Musculoskeletal Manipulations 1Methylprednisolone 1Lidoderm 1Lidocaine 1Indocyanine Green 1Electromyography 1Dry Needling 1Decompression 1Cryosurgery 1Cholecalciferol 1Botulinum Toxins, Type A 1Bevacizumab 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroma × Bevacizumab × Clear all
NCT01083966 2025-04-09

Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma

Northwell Health

Phase 1 Suspended
30 enrolled
CNS

Brain Neoplasms, Neurilemmoma, Neuroma, Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡